Aqua Bio Technology ASA (OSL:ABTEC)

Market Cap	95.78M
Revenue (ttm)	107.17M
Net Income (ttm)	-337.35M
Shares Out	108.84M
EPS (ttm)	-4.96
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	221,234
Average Volume	773,441
Open	0.9200
Previous Close	0.8950
Day's Range	0.8660 - 0.9200
52-Week Range	0.4620 - 4.0500
Beta	0.78
RSI	44.83
Earnings Date	Aug 27, 2025

About Aqua Bio Technology ASA

Aqua Bio Technology ASA engages in the manufacture and sale of ingredients for cosmetic industry in Norway. It offers Aquabeautine XL, a proprietary ingredient for skincare products; and Spirulysat, an antioxidant and vitamin-boosted spirulina for cosmetic use. The company distributes its products through Internet, stores, and skincare clinics. Aqua Bio Technology ASA was founded in 2000 and is based in Oslo, Norway.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2000
• Employees: 37
• Stock Exchange: Oslo Børs
• Ticker Symbol: ABTEC

Financial Performance

In 2024, Aqua Bio Technology ASA's revenue was 107.17 million, an increase of 472.00% compared to the previous year's 18.74 million. Losses were -337.35 million, 1504.6% more than in 2023.